Showing results (121-130 of 161) with videos related to
Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Macrophage angiotensin II type 2 receptor triggers neuropathic painAndrew J Shepherd, Aaron D Mickle, Judith P Golden, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2021
HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal StudyDavid J Margolis, Nandita Mitra, Brian S Kim, et al.JAAD International|July 15, 2024
Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)Gil Yosipovitch, Brian S Kim, Shawn G Kwatra, et al.The Journal of Experimental Medicine|June 11, 2024
A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in miceKelsey A Toth, Erica G Schmitt, Ana Kolicheski, et al.The Journal of Allergy and Clinical Immunology|July 15, 2023
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitisEmma Guttman-Yassky, Paola Facheris, Joel Correa Da Rosa, et al.Journal of the American Academy of Dermatology|March 6, 2020
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOSJonathan I Silverberg, Gil Yosipovitch, Eric L Simpson, et al.Immunity|July 1, 2018
TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle CellsJialie Luo, Aihua Qian, Landon K Oetjen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.Archives of Dermatological Research|October 22, 2016
CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214Bernice M Benoit, Neha Jariwala, Geraldine O'Connor, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigoLea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.Pageof 17